Latest News and Press Releases
Want to stay updated on the latest news?
-
Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan) in FSGS
-
Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team
-
Ligand to Participate in March Investor Conferences
-
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
-
Ligand to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
Ligand to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
-
Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
-
Ligand Reports Third Quarter 2025 Financial Results and Raises Guidance
-
Ligand to Participate in November Investor Conferences
-
Ligand to Report Third Quarter 2025 Financial Results on November 6, 2025